Showing results (131-140 of 443) with videos related to
Sort By:
Pageof 45
Cancer Cell|October 11, 2020
Cytokine Storms in Cancer and COVID-19Casmir Turnquist, Bríd M Ryan, Izumi Horikawa, et al.Genome Research|July 24, 2012
Noise-mean relationship in mutated promotersGil Hornung, Raz Bar-Ziv, Dalia Rosin, et al.Human Mutation|May 15, 2002
The IARC TP53 database: new online mutation analysis and recommendations to usersMagali Olivier, Ros Eeles, Monica Hollstein, et al.Cell Death & Disease|June 27, 2024
Distinct functions of wild-type and R273H mutant Δ133p53α differentially regulate glioblastoma aggressiveness and therapy-induced senescenceSebastien M Joruiz, Natalia Von Muhlinen, Izumi Horikawa, et al.IARC Scientific Publications|April 2, 2004
TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancerMagali Olivier, S Perwez Hussain, Claude Caron de Fromentel, et al.Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Microenvironmental modulation of asymmetric cell division in human lung cancer cellsSharon R Pine, Bríd M Ryan, Lyuba Varticovski, et al.Neuroscience|June 18, 2022
Δ133p53α Protects Human Astrocytes from Amyloid-beta Induced Senescence and NeurotoxicityKyra Ungerleider, Jessica A Beck, Delphine Lissa, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 30, 2014
A combined prognostic serum interleukin-8 and interleukin-6 classifier for stage 1 lung cancer in the prostate, lung, colorectal, and ovarian cancer screening trialBríd M Ryan, Sharon R Pine, Anil K Chaturvedi, et al.Human Mutation|March 6, 2003
TP53 and liver carcinogenesisFrank Staib, S Perwez Hussain, Lorne J Hofseth, et al.Geroscience|August 7, 2025
The senescence-inhibitory p53 isoform Δ133p53α: enhancing cancer immunotherapy and exploring novel therapeutic approaches for senescence-associated diseasesShinji Nakamichi, Leo Yamada, Christopher Roselle, et al.Pageof 45